The FDA just published:  Guidance for Industry – Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification (PDF)

William Koustas (FDA Law Blog) writes, “The DSCSA tasked FDA with addressing three issues in this guidance: (1) identifying scenarios that could increase the risk of suspect product entering the supply chain; (2) recommending ways trading partners can identify and determine whether product is suspect; and (3) creating a process for trading partners to terminate illegitimate product notifications.  FDC Act § 582(h)(2).  The Draft Guidance addressed each of these three issues as follows:” . . .

Read the full article: via FDA Law Blog: And So It Begins: FDA Issues First DSCSA Guidance.

---

Go to DREprof.com: The Designated Representative and Exemptee Training Website

• CA Designated Representative online web-based training certification by SkillsPlus Intl Inc. – Available around-the-clock 24 x 7 – Available for iPad
• FL Certified Designated Representative (CDR) online exam prep course by SkillsPlus Intl Inc. – Lots of practice exams – Practice makes perfect! – Available around-the-clock 24 x 7
• The Designated Representative Institute

• CA HMDR Exemptee online internet-based training certification by SkillsPlus Intl Inc. – Enhanced for iPad
• The Exemptee Institute

Related articles

• FDA DSCSA Workshop – Meeting Materials
• FDA Law Blog: Interoperably Exchanging Information with FDA: Agency Holds First DSCSA Public Workshop
• The Differences Between The DSCSA, FDA Rules and Guidance – RxTrace
• Drug Supply Chain Security Act – Drug Supply Chain Security Act (DSCSA) Implementation Plan

Tags: CA, California, CDR, certificate, certification, class, course, designated representative, drug, DSCSA, FDA, FL, Florida, license, licensing, Pharmaceutical industry, program, Supply chain, training, wholesaler